Advanced Search

 

Study ID Status Title Patient Level Data
113159 Completed GPRD Cataract Study: Retrospective cohort study of cataract incidence among patients with Idiopathic Thrombocytopenic Purpura (ITP)
113159_1 Completed GPRD Cataract Study: Retrospective cohort study of cataract incidence among patients with Idiopathic Thrombocytopenic Purpura (ITP)
113160 Completed A Phase II, Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects Study Listed on ClinicalStudyDataRequest.com
113161 Completed A randomised, double-blind, placebo-controlled, multi-way crossover study to assess the effects of single oral doses of SRT2104 and prednisolone on biomarkers in blood in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
113164 Completed Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
113165 Completed A study to evaluate the safety and immunogenicity of a booster dose of GSK Biologicals’ HIV candidate vaccine (732461) after administration of chloroquine in healthy adults.
113166 Completed Safety, reactogenicity and immunogenicity study of GSK Biologicals’ pneumococcal vaccine GSK1024850A, given either as a booster dose or as a 2-dose catch-up immunization in healthy Malian children Study Listed on ClinicalStudyDataRequest.com
113171 Completed Safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ investigational vaccination regimen in children aged 12-23 months at the time of first vaccination. Study Listed on ClinicalStudyDataRequest.com
113172 Terminated Study of GSK2302024A Antigen-Specific Cancer Immunotherapeutic combined with standard neoadjuvant treatment in patients with WT1-positive primary invasive breast cancer
113173 Completed Study of GSK2302025A Antigen-Specific Cancer Immunotherapeutic in patients with metastatic melanoma
113174 Terminated Study of GSK2302032A Antigen-Specific Cancer Immunotherapeutic in patients with resectable Non-Small Cell Lung Cancer
113191 Completed A Human Phase 0, Microdose Drug-Drug Interaction Study with [14C]-GSK706769 and Ketoconazole in Healthy Male Volunteers
113199 Completed Safety, reactogenicity and immunogenicity study of GSK Biologicals’ pneumococcal vaccine GSK1024850A, given either as a booster dose or as a 2-dose catch-up immunization in healthy Nigerian children Study Listed on ClinicalStudyDataRequest.com
113201 Completed Assessment of Serious Event Outcomes in Subjects with Persistent Asthma Receiving Salmeterol
113201_1 Completed Assessment of Serious Event Outcomes in Subjects with Persistent Asthma Receiving Salmeterol
113203 Completed A randomized, double-blind, placebo controlled, parallel group, multi-centre, 2-week treatment study to evaluate the safety and efficacy of fluticasone furoate nasal spray 110 mcg in the treatment in the treatment of uncomplicated acute rhinosinusitis in adults and adolescents >= 12 years of age
113208 Completed A single centre, randomised, placebo-controlled, four-way cross over study to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled doses of GSK573719 and GW642444 as monotherapies and concurrently in healthy Japanese subjects Study Listed on ClinicalStudyDataRequest.com
113209 Completed A randomised, double-blind, placebo-controlled, dose ascending,3-way crossover study to assess the pharmacokinetics, safety andtolerability of repeat inhaled doses of nebulised GW870086X inhealthy adult male volunteers. Study Listed on ClinicalStudyDataRequest.com
113211 Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
113214 Completed An open-label, five-way, partially randomized crossover study to evaluate the regional gastrointestinal absorption of retigabine in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
113215 Completed A two part study to assess the pharmacokinetic performance of three retigabine modified release (MR) formulations after single dose and to assess the pharmacokinetics and tolerability of titration with retigabine MR Study Listed on ClinicalStudyDataRequest.com
113220 Active, Not Recruiting An Open-Label, Dose-Escalation, Phase I/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the BRAF Inhibitor GSK2118436 in Combination with the MEK Inhibitor GSK1120212 in Subjects with BRAF Mutant Metastatic Melanoma
113221 Completed A Phase 1, Double-Blind, Randomized Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects with Colorectal Cancer and Hepatic Metastases Study Listed on ClinicalStudyDataRequest.com
113222 Terminated A Phase II, Open-Label, Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination with Bortezomib in Patients with Multiple Myeloma Study Listed on ClinicalStudyDataRequest.com
113237 Completed Immunogenicity and safety study of a GlaxoSmithKline Biologicals’ candidate influenza vaccine GSK2321138A in healthy children Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.